Ï㽶ÊÓƵ

Despite studies that claim people with cancer are less likely to develop Alzheimer’s disease--raising the possibility that what triggers cancer also prevents the neurodegenerative disorder--a new investigation finds a more...

A study led by the Huntsman Cancer Institute at the Ï㽶ÊÓƵ of Utah could explain why elephants rarely get cancer. Published in the Journal of the American Medical Association (JAMA)...

Charlton Park has been named Chief Analytics Officer (CAO) for Ï㽶ÊÓƵ of Utah Hospitals and Clinics, a newly created position.

In its effort to develop and implement strategies to stop the spread of infectious diseases, including Ebola, in health care settings, the Centers for Disease Control and Prevention (CDC) has...

Researchers have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it. The finding was identified with...

Mario R. Capecchi, PhD, will be honored for his tremendous scientific contributions, which have had a profound impact on the understanding of cancer, including his groundbreaking work in the development...

Program honors 15 researchers nationwide with funds to support their work

By looking at the ends of double-stranded RNA, Dicer enzyme tells difference

Martin McMahon, Ph.D., joins Huntsman Cancer Institute (HCI) at the Ï㽶ÊÓƵ of Utah in August as Professor in the Department of Dermatology and HCI Senior Director of Pre-Clinical Translation.

It kills, on average, one American every hour. But Melanoma does not have to be fatal. If caught early the skin cancer is highly treatable.

The PAM50 breast cancer signature developed at the Ï㽶ÊÓƵ of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City.

Ï㽶ÊÓƵ of Utah researchers identify new technique for identifying cancerous moles

Cells with a mutation in the gene called K-Ras found mostly in cancers with the worst prognoses behave in ways that subvert the normal mechanisms of cell death